Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Enterprise Value (EV)

Microsoft Excel

Current Enterprise Value (EV)

Allergan Inc., current enterprise value calculation

Microsoft Excel
Current share price (P) $231.12
No. shares of common stock outstanding 300,237,694
US$ in thousands
Common equity (market value)1 69,390,936
Add: Preferred stock, $.01 par value; none issued (per books)
Add: Noncontrolling interest (per books) 10,000
Total equity 69,400,936
Add: Notes payable (per books) 72,100
Add: Convertible notes (per books)
Add: Long-term debt, excluding current maturities (per books) 2,085,300
Total equity and debt 71,558,336
Less: Cash and equivalents 4,911,400
Less: Short-term investments 55,000
Enterprise value (EV) 66,591,936

Based on: 10-K (reporting date: 2014-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 231.12 × 300,237,694


Historical Enterprise Value (EV)

Allergan Inc., EV calculation

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Share price1, 2 $231.12 $125.54 $107.05 $88.82 $72.90
No. shares of common stock outstanding1 300,237,694 298,467,649 298,083,478 304,442,771 305,677,123
US$ in thousands
Common equity (market value)3 69,390,936 37,469,629 31,909,836 27,040,607 22,283,862
Add: Preferred stock, $.01 par value; none issued (book value)
Add: Noncontrolling interest (book value) 10,000 6,300 25,500 22,800 23,400
Total equity 69,400,936 37,475,929 31,935,336 27,063,407 22,307,262
Add: Notes payable (book value) 72,100 55,600 48,800 83,900 28,100
Add: Convertible notes (book value) 642,500
Add: Long-term debt, excluding current maturities (book value) 2,085,300 2,098,300 1,512,400 1,515,400 1,534,200
Total equity and debt 71,558,336 39,629,829 33,496,536 28,662,707 24,512,062
Less: Cash and equivalents 4,911,400 3,046,100 2,701,800 2,406,100 1,991,200
Less: Short-term investments 55,000 603,000 260,600 179,900 749,100
Enterprise value (EV) 66,591,936 35,980,729 30,534,136 26,076,707 21,771,762

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Allergan Inc. Annual Report.

3 2014 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 231.12 × 300,237,694

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Allergan Inc. EV increased from 2012 to 2013 and from 2013 to 2014.